Chemical activators classified as C10orf105 Activators are compounds that have been identified to modulate a broad spectrum of cellular signaling pathways, which can lead to the activation of the protein encoded by the gene C10orf105. The identification of such activators relies on a variety of biochemical and molecular biology techniques. Researchers often utilize high-throughput screening methods to test large libraries of chemicals for their ability to alter the activity of target proteins. Once potential activators are identified, their effects are usually confirmed through more targeted experiments, such as reporter assays, to directly assess the influence on the promoter activity of the gene of interest or protein-protein interaction studies to observe the impact on the interaction network within the cell.
Further elucidation of the action of C10orf105 activators includes detailed studies of the affected signaling cascades. This can involve the use of various inhibitors or activators to dissect the pathway and establish the position of C10orf105 within it. For instance, activators that increase intracellular levels of second messengers like cAMP can be used alongside phosphodiesterase inhibitors to understand the dynamic regulation of cAMP-responsive elements by C10orf105. Similarly, the use of kinase inhibitors helps to map out the kinase-dependent signaling pathways that C10orf105 may participate in. Advanced techniques such as mass spectrometry and immunoprecipitation are employed to identify post-translational modifications on the C10orf105 protein that are induced by activators, providing insights into the direct regulatory mechanisms. These studies are complemented by imaging techniques, including fluorescence microscopy, to observe the localization changes of the C10orf105 protein in response to activator exposure, offering clues about its functional role in the cellular context.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering gene expression patterns, which can affect proteins involved in cell differentiation and proliferation, including the potential regulation of C10orf105. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases, can lead to changes in chromatin structure and gene expression, possibly affecting proteins implicated in cell cycle control such as C10orf105. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, can alter AKT signaling pathways, which can influence proteins involved in cell survival and growth, including possible effects on C10orf105. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, can affect the MAPK/ERK pathway, which is involved in cell proliferation and differentiation, potentially including modulation of C10orf105. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β receptor, can modulate cellular processes such as apoptosis and proliferation, which can include regulatory effects on proteins like C10orf105. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, can affect cell growth and protein synthesis pathways, which may include effects on proteins involved in these processes, such as C10orf105. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor, leads to increased cytosolic calcium levels, which can affect calcium-dependent signaling pathways, potentially including those involving C10orf105. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK, can alter ERK pathway signaling, with potential implications for proteins involved in cell cycle and growth, such as C10orf105. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, can affect proteins involved in apoptosis and inflammation signaling pathways, which could include modulation of C10orf105 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, can lead to the accumulation of polyubiquitinated proteins, which can modulate proteins involved in degradation pathways, including potentially C10orf105. | ||||||